NADAC acquisition cost data for AMBIEN 10 MG TABLET. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00024542131 | $19.65 | 2022-11-23 | Rx |
| 00024542131 | $19.65 | 2022-11-23 | Rx |
| 00024542131 | $19.65 | 2022-11-23 | Rx |
| 00024542131 | $19.65 | 2022-11-23 | Rx |
| 00024542131 | $19.65 | 2022-11-23 | Rx |
| 00024542131 | $19.65 | 2022-11-23 | Rx |
Generic: Zolpidem Tartrate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $13.1M | 20,683 | 3,557 | $17.22 |
| 2020 | $13.0M | 18,934 | 3,203 | $18.43 |
| 2021 | $12.8M | 17,498 | 2,934 | $19.59 |
| 2022 | $12.6M | 16,372 | 2,787 | $20.63 |
| 2023 | $12.1M | 14,902 | 2,421 | $21.93 |
These generic drugs may be equivalent alternatives at lower prices.
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $2.4M | 3,437 | 474 |
| California | $1.3M | 1,622 | 291 |
| New Jersey | $853.8K | 978 | 173 |
| Florida | $679.1K | 735 | 162 |
| Texas | $608.3K | 667 | 127 |
| Pennsylvania | $565.3K | 730 | 119 |
| Massachusetts | $515.9K | 628 | 98 |
| South Carolina | $460.0K | 589 | 95 |
| Connecticut | $427.8K | 465 | 77 |
| Michigan | $334.2K | 309 | 54 |
| North Carolina | $319.3K | 396 | 78 |
| Illinois | $315.9K | 298 | 57 |
| Wisconsin | $213.5K | 290 | 37 |
| Georgia | $211.3K | 241 | 47 |
| Arizona | $209.0K | 216 | 44 |
| Ohio | $205.5K | 249 | 47 |
| Minnesota | $199.8K | 237 | 30 |
| Colorado | $184.1K | 208 | 37 |
| Maryland | $182.0K | 170 | 38 |
| Virginia | $160.3K | 202 | 35 |
| Washington | $127.8K | 150 | 32 |
| Indiana | $119.8K | 154 | 25 |
| Kentucky | $115.9K | 148 | 22 |
| Tennessee | $115.3K | 161 | 26 |
| Missouri | $101.3K | 113 | 20 |
| Alaska | $87.1K | 74 | 19 |
| Louisiana | $84.4K | 120 | 21 |
| Oklahoma | $81.3K | 124 | 18 |
| New Hampshire | $76.6K | 77 | 14 |
| New Mexico | $74.6K | 78 | 15 |
| Nevada | $73.2K | 77 | 17 |
| Utah | $68.1K | 74 | 13 |
| Maine | $67.6K | 95 | 13 |
| Alabama | $64.9K | 78 | 14 |
| Iowa | $54.4K | 57 | N/A |
| Hawaii | $53.2K | 59 | 11 |
| Oregon | $45.8K | 56 | 15 |
| Arkansas | $43.6K | 51 | 11 |
| Delaware | $41.1K | 54 | N/A |
| South Dakota | $40.7K | 65 | N/A |
| Rhode Island | $39.2K | 68 | 12 |
| Kansas | $36.6K | 34 | N/A |
| Nebraska | $36.3K | 52 | N/A |
| Idaho | $35.1K | 38 | N/A |
| Vermont | $33.8K | 65 | N/A |
| District of Columbia | $24.8K | 28 | N/A |
| Mississippi | $23.5K | 33 | N/A |
| West Virginia | $22.0K | 22 | N/A |
| Montana | $15.4K | 15 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.